• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻智利苯丙酮尿症患者的肌肉和骨骼健康与不同程度的遵守苯丙氨酸限制饮食的关系。

Muscle and Bone Health in Young Chilean Adults with Phenylketonuria and Different Degrees of Compliance with the Phenylalanine Restricted Diet.

机构信息

Instituto de Nutrición y Tecnología de Alimentos INTA, Universidad de Chile, Santiago 7830490, Chile.

出版信息

Nutrients. 2023 Jun 28;15(13):2939. doi: 10.3390/nu15132939.

DOI:10.3390/nu15132939
PMID:37447265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10346392/
Abstract

UNLABELLED

There are concerns about muscle and bone health in patients with Phenylketonuria (PKU). Our aim was to compare muscle mass, function, and bone health among young adults with PKU who maintained or suspended dietary treatment.

METHODS

Three groups were considered-PKU-1: 10 patients who used a protein substitute (PS) without phenylalanine (Phe); PKU-2: 14 patients who used the PS without Phe until eighteen years old and then practiced mostly a vegan diet; and 24 matched healthy controls. A 24 h recall survey, blood parameters, body composition and bone mineral density through DEXA, rectus femoris thickness by ultrasound, hand grip strength, submaximal exercise test, and walking speed were assessed.

RESULTS

PKU-1 patients had lower hand grip strength than their matched controls, but no other differences. Compared to controls, the PKU-2 group had lower fat-free mass ( = 0.01), less spine and femoral bone mineral density ( = 0.04 and < 0.01, respectively), and peak workload on the incremental test ( = 0.03). When comparing PKU groups, blood Phe levels were significantly lower in the PKU-1 group ( = 0.02).

CONCLUSIONS

Among PKU patients, abandoning the dietary treatment and maintaining high blood Phe concentrations could be deleterious for muscles and bones. However, we cannot discard other causes of bone and muscle damage in these patients.

摘要

未加标签

苯丙酮尿症(PKU)患者存在肌肉和骨骼健康问题。我们的目的是比较坚持或停止饮食治疗的年轻成年 PKU 患者的肌肉质量、功能和骨骼健康。

方法

考虑了三组患者-PKU-1:10 名使用不含苯丙氨酸(Phe)的蛋白质替代物(PS)的患者;PKU-2:14 名在 18 岁之前使用不含 Phe 的 PS,然后主要实行素食饮食的患者;以及 24 名匹配的健康对照者。通过 24 小时回顾性调查、血液参数、DEXA 测量的身体成分和骨矿物质密度、超声测量股直肌厚度、手握力、亚最大运动测试和步行速度评估。

结果

PKU-1 患者的手握力低于其匹配的对照组,但没有其他差异。与对照组相比,PKU-2 组的无脂肪质量较低(=0.01),脊柱和股骨骨矿物质密度较低(=0.04 和 <0.01,分别),递增测试的峰值工作量较低(=0.03)。当比较 PKU 组时,PKU-1 组的血液 Phe 水平明显较低(=0.02)。

结论

在 PKU 患者中,放弃饮食治疗并保持高血液 Phe 浓度可能对肌肉和骨骼有害。然而,我们不能排除这些患者骨骼和肌肉损伤的其他原因。

相似文献

1
Muscle and Bone Health in Young Chilean Adults with Phenylketonuria and Different Degrees of Compliance with the Phenylalanine Restricted Diet.年轻智利苯丙酮尿症患者的肌肉和骨骼健康与不同程度的遵守苯丙氨酸限制饮食的关系。
Nutrients. 2023 Jun 28;15(13):2939. doi: 10.3390/nu15132939.
2
Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria.培维索酶与成人苯丙酮尿症标准治疗比较对照的长期疗效比较。
Mol Genet Metab. 2019 Sep-Oct;128(1-2):92-101. doi: 10.1016/j.ymgme.2019.07.018. Epub 2019 Aug 7.
3
Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density.苯丙酮尿症患者的脂肪酸谱及其与骨密度的关系。
J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S363-71. doi: 10.1007/s10545-010-9189-0. Epub 2010 Sep 10.
4
The Impact of Phenylketonuria on Body Composition in Adults.苯丙酮尿症对成年人身体成分的影响。
Ann Nutr Metab. 2022;78(2):98-105. doi: 10.1159/000520047. Epub 2021 Dec 6.
5
Meta-analysis of bone mineral density in adults with phenylketonuria.成人生酮饮食治疗苯丙酮尿症患者的骨密度 meta 分析
Orphanet J Rare Dis. 2024 Sep 12;19(1):338. doi: 10.1186/s13023-024-03223-9.
6
The relationship between dietary intake, growth and body composition in Phenylketonuria.苯丙酮尿症患者的饮食摄入、生长和身体成分之间的关系。
Mol Genet Metab. 2017 Sep;122(1-2):36-42. doi: 10.1016/j.ymgme.2017.07.007. Epub 2017 Jul 20.
7
Systematic literature review of the somatic comorbidities experienced by adults with phenylketonuria.成人苯丙酮尿症患者躯体共病的系统文献综述。
Orphanet J Rare Dis. 2024 Aug 12;19(1):293. doi: 10.1186/s13023-024-03203-z.
8
Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.过度限制饮食蛋白质摄入量:苯丙酮尿症中持续重新评估天然蛋白质耐受性的重要性。
Nutrients. 2019 Apr 30;11(5):995. doi: 10.3390/nu11050995.
9
Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients.苯丙酮尿症患者腰椎骨密度与生化参数的关系。
Mol Genet Metab. 2012 Apr;105(4):566-70. doi: 10.1016/j.ymgme.2012.01.006. Epub 2012 Jan 16.
10
Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.骨强度降低是苯丙酮尿症小鼠的表现,而糖巨肽饮食可减轻这种情况。
PLoS One. 2012;7(9):e45165. doi: 10.1371/journal.pone.0045165. Epub 2012 Sep 18.

引用本文的文献

1
Vitamin B12 and Folate in Adherent and Non-Adherent Individuals with Phenylketonuria: A Cross-Sectional Study, Systematic Review, and Meta-Analysis.苯丙酮尿症依从性和非依从性个体中的维生素B12和叶酸:一项横断面研究、系统评价和荟萃分析
Metabolites. 2025 Jul 1;15(7):438. doi: 10.3390/metabo15070438.
2
Adults with Phenylketonuria have suboptimal bone mineral density apart from vitamin D and calcium sufficiency.除维生素D和钙充足外,患有苯丙酮尿症的成年人骨矿物质密度仍不理想。
Front Endocrinol (Lausanne). 2025 Feb 14;16:1488215. doi: 10.3389/fendo.2025.1488215. eCollection 2025.
3
Current Insights into Nutritional Management of Phenylketonuria: An Update for Children and Adolescents.苯丙酮尿症营养管理的最新见解:儿童和青少年最新情况
Children (Basel). 2025 Feb 7;12(2):199. doi: 10.3390/children12020199.
4
Meta-analysis of bone mineral density in adults with phenylketonuria.成人生酮饮食治疗苯丙酮尿症患者的骨密度 meta 分析
Orphanet J Rare Dis. 2024 Sep 12;19(1):338. doi: 10.1186/s13023-024-03223-9.
5
Nutrient Status and Intakes of Adults with Phenylketonuria.苯丙酮尿症成人的营养状况和摄入量。
Nutrients. 2024 Aug 15;16(16):2724. doi: 10.3390/nu16162724.
6
Systematic literature review of the somatic comorbidities experienced by adults with phenylketonuria.成人苯丙酮尿症患者躯体共病的系统文献综述。
Orphanet J Rare Dis. 2024 Aug 12;19(1):293. doi: 10.1186/s13023-024-03203-z.
7
No Impairment in Bone Turnover or Executive Functions in Well-Treated Preschoolers with Phenylketonuria-A Pilot Study.苯丙酮尿症患儿经良好治疗后,骨代谢和执行功能无损害:一项初步研究。
Nutrients. 2024 Jun 28;16(13):2072. doi: 10.3390/nu16132072.
8
Morphofunctional Assessment beyond Malnutrition: Fat Mass Assessment in Adult Patients with Phenylketonuria-Systematic Review.肥胖症评估在苯丙酮尿症成年患者中的应用:系统综述
Nutrients. 2024 Jun 11;16(12):1833. doi: 10.3390/nu16121833.
9
Vitamin Status in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis.苯丙酮尿症患者的维生素状况:系统评价和荟萃分析。
Int J Mol Sci. 2024 May 7;25(10):5065. doi: 10.3390/ijms25105065.
10
Intake Modalities of Amino Acid Supplements: A Real-World Data Collection from Phenylketonuria Patients.氨基酸补充剂的摄入方式:苯丙酮尿症患者的真实世界数据收集。
Nutrients. 2024 Feb 27;16(5):669. doi: 10.3390/nu16050669.

本文引用的文献

1
Management of early treated adolescents and young adults with phenylketonuria: Development of international consensus recommendations using a modified Delphi approach.早期治疗的苯丙酮尿症青少年和年轻成人的管理:使用改良 Delphi 方法制定国际共识建议。
Mol Genet Metab. 2022 Sep-Oct;137(1-2):114-126. doi: 10.1016/j.ymgme.2022.07.012. Epub 2022 Jul 29.
2
Protein status in phenylketonuria: A scoping review.苯丙酮尿症患者的蛋白质状况:范围综述。
Clin Nutr. 2022 Apr;41(4):894-922. doi: 10.1016/j.clnu.2022.02.010. Epub 2022 Feb 18.
3
Improved attention linked to sustained phenylalanine reduction in adults with early-treated phenylketonuria.早期治疗苯丙酮尿症患者中苯丙氨酸持续降低与注意力改善相关。
Am J Med Genet A. 2022 Mar;188(3):768-778. doi: 10.1002/ajmg.a.62574. Epub 2021 Nov 26.
4
Vitamin D status and obesity in children from Chile.智利儿童的维生素 D 状况与肥胖。
Eur J Clin Nutr. 2022 Jun;76(6):899-901. doi: 10.1038/s41430-021-01043-9. Epub 2021 Nov 12.
5
Cardiorespiratory Fitness: Reference on the Six-Minute Walk Test and Oxygen Consumption in Adolescents from South-Central Chile.心肺适能:智利中南部青少年六分钟步行试验和耗氧量参考值。
Int J Environ Res Public Health. 2021 Mar 3;18(5):2474. doi: 10.3390/ijerph18052474.
6
PKU dietary handbook to accompany PKU guidelines.苯丙酮尿症饮食手册,用以配合苯丙酮尿症指南。
Orphanet J Rare Dis. 2020 Jun 30;15(1):171. doi: 10.1186/s13023-020-01391-y.
7
Nutrient intake, body composition, and blood phenylalanine control in children with phenylketonuria compared to healthy controls.与健康对照组相比,苯丙酮尿症患儿的营养摄入、身体组成和血液苯丙氨酸控制情况。
Mol Genet Metab Rep. 2020 May 11;23:100599. doi: 10.1016/j.ymgmr.2020.100599. eCollection 2020 Jun.
8
Metabolic and catecholamine response to sympathetic stimulation in early-treated adult male patients with phenylketonuria.早期治疗的成年男性苯丙酮尿症患者对交感神经刺激的代谢和儿茶酚胺反应。
Hormones (Athens). 2020 Sep;19(3):395-402. doi: 10.1007/s42000-020-00176-z. Epub 2020 Jan 28.
9
Fitness and Body Mass Index During Adolescence and Disability Later in Life: A Cohort Study.青少年时期的健康和身体质量指数与晚年的残疾:一项队列研究。
Ann Intern Med. 2019 Feb 19;170(4):230-239. doi: 10.7326/M18-1861. Epub 2019 Feb 12.
10
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018年美国心脏协会/美国心脏病学会/美国心血管和肺康复协会/美国医师助理学会/美国心脏协会心血管病理事会/美国预防医学学院/美国糖尿病协会/美国老年医学会/美国药剂师协会/美国医学主任协会/美国国家脂质协会/美国初级保健医师学会血液胆固醇管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Jun 18;139(25):e1046-e1081. doi: 10.1161/CIR.0000000000000624. Epub 2018 Nov 10.